Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

ClinicalTrials.gov ID: NCT03000348

Public ClinicalTrials.gov record NCT03000348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease

Study identification

NCT ID
NCT03000348
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NovaBiotics Ltd.
Industry
Enrollment
91 participants

Conditions and interventions

Interventions

  • Cysteamine Drug
  • Placebo Oral Capsule Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Mar 31, 2018
Completion
Mar 31, 2018
Last update posted
Apr 13, 2021

2016 – 2018

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Banner University of Arizona Medical Center Tucson Arizona 85724
San Francisco Critical Care Medical Group California Pacific Medical Center San Francisco California 94115
University of Florida Gainesville Florida 32610
Central Florida Pulmonary Orlando Florida 32803
Albany Medical College Albany New York 12208
Nationwide Children's Hospital Columbus Ohio 43205
West Virginia University Morgantown West Virginia 26506
The Medical College of Wisconsin/Froedtert Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03000348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03000348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →